Author Archives: JAIDS

Prevalence of Anal Human Papillomavirus Infection Among HIV-Infected Women From India

No abstract available

Posted in Journal Watch | Comments closed

Words Matter: Discussing Research Towards an HIV Cure in Research and Clinical Contexts

No abstract available

Posted in Journal Watch | Comments closed

Process Monitoring of an HIV Treatment as Prevention Program in British Columbia, Canada

Background: In light of accumulated scientific evidence of the secondary preventive benefits of antiretroviral therapy, a growing number of jurisdictions worldwide have formally started to implement HIV Treatment as Prevention (TasP) programs.

Posted in Journal Watch | Comments closed

T-Cell Activation, Both Pre- and Post-HAART Levels, Correlates With Carotid Artery Stiffness…

Objective: T-cell activation is a major pathway driving HIV disease progression.

Posted in Journal Watch | Comments closed

A Mathematical Model Evaluating the Timing of Early Diagnostic Testing in HIV-Exposed Infants…

Background: Antiretroviral therapy is often initiated too late to impact early HIV-related infant mortality.

Posted in Journal Watch | Comments closed

Did CDC’s 2006 Revised HIV Testing Recommendations Make a Difference? Evaluation of HIV Testing…

Objective: To examine changes in the prevalence of HIV testing among adults following the Centers for Disease Control and Prevention’s 2006 revised HIV testing recommendations.

Posted in Journal Watch | Comments closed

Use of Multiple Data Sources and Individual Case Investigation to Refine Surveillance-Based…

Objectives: To assess the HIV care continuum among HIV-infected persons residing in Seattle and King County, WA, at the end of 2011 and compare estimates of viral suppression derived from different population-based data sources.

Posted in Journal Watch | Comments closed

Neurodevelopmental Benefits of Antiretroviral Therapy in Ugandan Children Aged 0–6 Years With…

Background: Insufficient data on neurodevelopmental benefits of antiretroviral therapy (ART) in children.

Posted in Journal Watch | Comments closed

Diagnostic Delays and Clinical Decision Making With Centralized Xpert MTB/RIF Testing in…

Setting: We conducted a retrospective study among HIV-infected adult suspects (≥18 years) with pulmonary tuberculosis (TB), who underwent Xpert MTB/RIF (Xpert) testing at McCord Hospital and its adjoining HIV clinic in Durban, South Africa.

Posted in Journal Watch | Comments closed

Raltegravir Pharmacokinetics in Neonates Following Maternal Dosing

Abstract: International Maternal Pediatric Adolescent AIDS Clinical Trials P1097 was a multicenter trial to determine washout pharmacokinetics and safety of in utero/intrapartum exposure to raltegravir in infants born to HIV-infected pregnant women receiving raltegravir-based antiretroviral therapy.

Posted in Journal Watch | Comments closed

Management of Fever in Ambulatory HIV-Infected Adults in Resource-Limited Settings: …

Abstract: A new Mozambican guideline for management of fever in HIV-infected adults requires malaria testing and systematic consideration of specific alternative diagnoses (eg, tuberculosis and bacterial infections) in addition to malaria.

Posted in Journal Watch | Comments closed

Association of Chronic Hepatitis C Infection With T-Cell Phenotypes in HIV-Negative and…

Background: Hepatitis C virus (HCV) viremia is thought to have broad systemic effects on the cellular immune system that go beyond its impact on just those T cells that are HCV specific.

Posted in Journal Watch | Comments closed

Association of Markers of Hemostasis With Death in HIV-Infected Women

Abstract: In HIV negatives, markers of hemostasis, including D-dimer, factor VIII, plasminogen activator inhibitor-1 antigen (PAI-1), and total protein S are associated with all-cause and cardiovascular disease mortality.

Posted in Journal Watch | Comments closed

Impact of Adherence and Anthropometric Characteristics on Nevirapine Pharmacokinetics and…

Background: There are insufficient data on pediatric antiretroviral therapy (ART) pharmacokinetics (PK), particularly for children in low- and middle-income countries.

Posted in Journal Watch | Comments closed